semaglutide blindness study Ozempic, Wegovy may be linked to risk of NAION rare form of blindness: Study reveals potential eye risk

Its distinctive mechanism of action reduces the absorption of fats, potentially benefiting insulin sensitivity and reducing levels of circulating fatty acids

The gastrointestinal side effects often subside as patients acclimate to the treatment but do lead to treatment discontinuation for some patients

Metabolic changes that show up in bloodwork (better fasting glucose, improved A1c, lower triglycerides) take 6 to 8 weeks to register

It works by enhancing insulin secretion, suppressing glucagon release, and slowing gastric emptying, which collectively improves glycaemic control and often leads to weight loss

The subcutaneous tissuethe fatty layer just beneath your skincontains many tiny capillaries that can bleed when punctured